Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Long-term Follow-up ...
From CRISPR to gene banking, synthetic biology has big implications for wildlife evolution and conservation, but ethical ...
When Demetri Maxim was seven years old, his mother’s kidneys stopped working. She was put on dialysis, which meant that she ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by ...
The CRISPR gene editing technology has transformed the research lab, and this powerful tool is now making its way into the clinic. So far, three different human diseases have been successfully treated ...
One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective DNA and fix genetic diseases like sickle cell anemia, and chronic disorders ...
Explore opportunities in protein engineering to innovate therapeutic and industrial applications. Enhance your skills in molecular biology and protein chemistry to develop cutting-edge protein-based ...
A detailed look at the predicted structure of a new CRISPR-Cas tool that promises to expand the genomic editing and manipulating abilities of the original. Researchers at Duke University and North ...
Down syndrome affects around one in 640 children born in the US every year, and is the most common genetic cause of intellectual disability... | Cell And Molecular Biology ...
7don MSN
Reid Hoffman says Silicon Valley's got a blind spot that savvy AI investors could be cashing in on
Reid Hoffman says the next great AI companies will rise from Silicon Valley's blind spot — not from software and code.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback